quinuclidines has been researched along with Asialia in 53 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.89) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 38 (71.70) | 29.6817 |
| 2010's | 14 (26.42) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cimmino, J; Farag, AM; Holliday, C; Papas, A; Roomian, T | 1 |
| Barbe, AG | 2 |
| Forbes, B; Garcia, CMA; Malallah, OS; Proctor, GB; Royall, PG | 1 |
| Cherubini, K; Figueiredo, MAZ; Medella-Junior, FAC; Salum, FG | 1 |
| Chimenos Küstner, E; Jané Salas, E; López-López, J | 1 |
| Li, J; Li, P; Liu, B; Wang, Y; Wu, Y | 1 |
| Cheon, SY; Cho, SY; Choi, JB; Choo, MS; Chun, JY; Kim, JC; Kim, JH; Lee, KS; Oh, SJ; Park, J; Seo, JT; Song, M | 1 |
| Kawakami, A; Nakamura, H; Nakamura, T; Sato, S; Sumi, M; Takagi, Y | 1 |
| Katayama, I; Nakamura, T; Takagi, Y; Tashiro, S | 1 |
| Hashiramoto, A; Komai, K; Murata, M; Sakai, H; Shiozawa, K; Shiozawa, S; Tanaka, C; Tanaka, Y; Tsumiyama, K; Yamane, T; Yoshihara, R | 1 |
| Barkin, J; Carlson, K; Drutz, H; Egerdie, B; Gajewski, JB; Herschorn, S; Paradiso-Hardy, F; Pommerville, P; Radomski, S; Schulz, J; Stothers, L | 1 |
| Cho, G; Inoue, N; Ishikawa, Y; Shono, M; Wang, D; Yuan, Z | 1 |
| Chambers, MS; Stinnett, S; Witsell, DL | 1 |
| Brubaker, L; Khandwala, S; Lowder, J; Meikle, SF; Menefee, SA; Nolen, TL; Nygaard, I; Paraiso, MF; Richter, HE; Schaffer, J; Sirls, L; Spino, C; Visco, AG; Wallace, D | 1 |
| Fukumoto, K; Hara, R; Koide, T; Miyaji, Y; Nagai, A; Yokoyama, T | 1 |
| Nieuw Amerongen, AV; Veerman, EC | 1 |
| Asari, T; Kojima, M; Kusama, H; Maruyama, K; Omori, Y; Shibata, N | 1 |
| Bruce, SD | 1 |
| Kimura, Y; Nakamura, T; Takagi, Y | 1 |
| Sand, PK | 1 |
| Fukushima, T; Hirose, Y; Karasawa, H; Masaki, Y; Ogawa, N; Shimoyama, K; Sugai, S; Wano, Y | 1 |
| Cardozo, L; Chapple, C; Haab, F; Ridder, AM | 1 |
| Matsumoto, M; Nakanishi, T; Nakashima, M; Ohsuzu, F; Okada, M; Suzuki, K; Takada, K | 1 |
| Shetty, K | 2 |
| Atkinson, JC; Grisius, M; Massey, W | 1 |
| Al-Hashimi, I | 1 |
| Johnstone, PA; Kahn, ST | 1 |
| Carpenter, PA; Flowers, ME; Schubert, MM | 1 |
| Mishima, K; Nakagawa, Y; Nomura, Y; Saito, I; Sumida, T; Wakamatsu, E; Yamachika, S; Yamada, H | 1 |
| Gause, A | 1 |
| Garely, AD; Lucente, V; Smith, N; Vapnek, J | 1 |
| Brennan, MT; Carrozzo, M; Daniels, T; Fox, PC; Fujibayashi, T; Gandera, B; Jonsson, R; Lockhart, PB; Navazesh, M; Rhodus, NL; Schiødt, M; Sollecito, TP; von Bültzingslöwen, I; Wray, D | 1 |
| Armstrong, I; Biel, MA; Chambers, MS; Hodge, KM; Jones, CU; Posner, M; Vitti, R; Weber, RS; Yen, C | 1 |
| Gotoh, M; Ishizuka, O; Itoh, N; Kakizaki, H; Marui, E; Okada, H; Ozono, S; Seki, N; Sugiyama, T; Yamaguchi, O; Yokota, T; Yoshida, M | 1 |
| Armstrong, I; Biel, MA; Chambers, MS; Chen, Y; Garden, AS; Haddad, R; Hodge, KM; Holland, JM; Jones, CU; Ship, JA; Vitti, R; Weber, RS | 1 |
| Lau, CS; Leung, KC; Leung, WK; McMillan, AS; Mok, MY; Wong, MC | 1 |
| Hanaue, N; Kizu, Y; Takaki, S; Takakura, K; Takeda, I; Tonogi, M; Yamane, GY | 1 |
| Wick, JY | 1 |
| al-Hashimi, I; Taylor, SE | 1 |
| Atkinson, JC; Baum, BJ | 1 |
| Arisawa, H; Fujise, N; Fukui, K; Imai, E; Masunaga, H | 2 |
| Arisawa, H; Fujise, N; Fukui, K; Masunaga, H | 1 |
| Cohen, S; Condemi, JJ; Dalgin, P; Fife, R; Gluck, O; Petrone, D | 1 |
| Arisawa, H; Fukui, K; Masunaga, H | 1 |
| Muzyka, BC | 1 |
| Chase, WF; Dore, RK; Fife, RS; Lockhart, PB; Suen, JY; Tindall, E; Wiesenhutter, CW | 1 |
| Russell Taylor, WJ | 1 |
13 review(s) available for quinuclidines and Asialia
| Article | Year |
|---|---|
Buccal drug delivery technologies for patient-centred treatment of radiation-induced xerostomia (dry mouth).
Topics: Drug Delivery Systems; Head and Neck Neoplasms; Humans; Mouth Mucosa; Muscarinic Agonists; Pilocarpine; Quinuclidines; Radiation Injuries; Saliva; Thiophenes; Time Factors; Xerostomia | 2018 |
Salivary hypofunction: An update on therapeutic strategies.
Topics: Acupuncture Therapy; Bethanechol; Chewing Gum; Humans; Hyperbaric Oxygenation; Muscarinic Agonists; Pilocarpine; Quinuclidines; Thiophenes; Xerostomia | 2018 |
Medication-Induced Xerostomia and Hyposalivation in the Elderly: Culprits, Complications, and Management.
Topics: Aged; Humans; Polypharmacy; Prevalence; Quality of Life; Quinuclidines; Saliva; Thiophenes; Xerostomia | 2018 |
[Prognosis and treatment of dry mouth. Systematic review].
Topics: Cholinergic Antagonists; Clinical Trials as Topic; Dental Caries; Disease Susceptibility; Double-Blind Method; Fluid Therapy; Humans; Meta-Analysis as Topic; Mouthwashes; Observational Studies as Topic; Pilocarpine; Prognosis; Quinuclidines; Radiation Injuries; Radiotherapy; Saliva, Artificial; Salivation; Sjogren's Syndrome; Thiophenes; Xerostomia | 2014 |
[Comparisons of therapeutic efficacy and safety of solifenacin versus tolterodine in patients with overactive bladder: a meta-analysis of outcomes].
Topics: Benzhydryl Compounds; Constipation; Cresols; Humans; Phenylpropanolamine; Quinuclidines; Safety; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Xerostomia | 2014 |
Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies.
Topics: Acupuncture Therapy; Antineoplastic Agents; Chewing Gum; Diet; Flavoring Agents; Humans; Muscarinic Agonists; Neoplasms; Oral Hygiene; Palliative Care; Parasympathomimetics; Pilocarpine; Quinuclidines; Radiotherapy; Saliva; Salivary Glands; Thiophenes; Xerostomia | 2003 |
Radiation-induced xerostomia: how dry is your patient?
Topics: Acupuncture Therapy; Head and Neck Neoplasms; Humans; Muscarinic Agonists; Nurse's Role; Nursing Assessment; Oncology Nursing; Oral Hygiene; Pilocarpine; Quality of Life; Quinuclidines; Radiotherapy; Radiotherapy Dosage; Salivation; Thiophenes; Xerostomia | 2004 |
Elevating our therapeutic expectations in overactive bladder.
Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Constipation; Cresols; Delayed-Action Preparations; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Vision Disorders; Xerostomia | 2004 |
Salivary hypofunction and xerostomia: diagnosis and treatment.
Topics: Aged; Aged, 80 and over; Cariostatic Agents; Fluorides; Humans; Pilocarpine; Polypharmacy; Quinuclidines; Radiotherapy; Salivation; Sjogren's Syndrome; Thiophenes; Xerostomia | 2005 |
Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Humans; Muscarinic Agonists; Pilocarpine; Quinuclidines; Sjogren's Syndrome; Thiophenes; Xerostomia | 2005 |
Management of xerostomia related to radiotherapy for head and neck cancer.
Topics: Acupuncture Therapy; Amifostine; Clinical Trials as Topic; Head and Neck Neoplasms; Humans; Muscarinic Agonists; Palliative Care; Pilocarpine; Quinuclidines; Radiation-Protective Agents; Radiotherapy; Submandibular Gland; Thiophenes; Xerostomia | 2005 |
Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Diabetes Complications; HIV Infections; Humans; Interferon-alpha; Muscarinic Agonists; Pilocarpine; Quinuclidines; Rituximab; Salivation; Sjogren's Syndrome; Thiophenes; Xerostomia | 2007 |
Xerostomia: causes and treatment.
Topics: Autoimmune Diseases; Bone Marrow Transplantation; Drug-Related Side Effects and Adverse Reactions; Humans; Pilocarpine; Quinuclidines; Saliva; Thiophenes; Xerostomia | 2007 |
16 trial(s) available for quinuclidines and Asialia
| Article | Year |
|---|---|
Parotid irrigation and cevimeline gargle for treatment of xerostomia in Sjögren's syndrome.
Topics: Humans; Mouthwashes; Parasympathomimetics; Parotid Gland; Quinuclidines; Sjogren's Syndrome; Steroids; Therapeutic Irrigation; Thiophenes; Xerostomia | 2008 |
Tolerability of 5 mg solifenacin once daily versus 5 mg oxybutynin immediate release 3 times daily: results of the VECTOR trial.
Topics: Adult; Aged; Aged, 80 and over; Canada; Chi-Square Distribution; Double-Blind Method; Drug Administration Schedule; Female; Humans; Incidence; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Surveys and Questionnaires; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Xerostomia | 2010 |
Effectiveness of cevimeline to improve oral health in patients with postradiation xerostomia.
Topics: Carcinoma, Squamous Cell; Double-Blind Method; Female; Head and Neck Neoplasms; Humans; Male; Muscarinic Agonists; Oral Health; Quality of Life; Quinuclidines; Radiotherapy; Salivary Glands; Severity of Illness Index; Thiophenes; Xerostomia | 2012 |
Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence.
Topics: Aged; Benzilates; Botulinum Toxins, Type A; Cholinergic Antagonists; Double-Blind Method; Female; Humans; Intention to Treat Analysis; Linear Models; Middle Aged; Nortropanes; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Incontinence, Urge; Urinary Retention; Urinary Tract Infections; Xerostomia | 2012 |
Long-term safety and efficacy of two different antimuscarinics, imidafenacin and solifenacin, for treatment of overactive bladder: a prospective randomized controlled study.
Topics: Aged; Female; Follow-Up Studies; Humans; Imidazoles; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; Urinary Bladder, Overactive; Xerostomia | 2013 |
Long-term open-label solifenacin treatment associated with persistence with therapy in patients with overactive bladder syndrome.
Topics: Constipation; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Multivariate Analysis; Patient Compliance; Patient Satisfaction; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Time; Treatment Outcome; Urinary Incontinence; Vision Disorders; Xerostomia | 2005 |
Effect of cevimeline on salivary components in patients with Sjögren syndrome.
Topics: alpha-Amylases; Antigens, Neoplasm; Female; Humans; Immunoglobulin A; Middle Aged; Muramidase; Muscarinic Agonists; Quinuclidines; Saliva; Salivation; Serpins; Sjogren's Syndrome; Thiophenes; Xerostomia | 2005 |
Efficacy prediction of cevimeline in patients with Sjögren's syndrome.
Topics: Adult; Aged; Female; Humans; Middle Aged; Parasympathomimetics; Parotid Gland; Prognosis; Quinuclidines; Receptors, Muscarinic; Salivation; Sialography; Sjogren's Syndrome; Thiophenes; Treatment Outcome; Xerostomia | 2007 |
Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Constipation; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Visual Acuity; Xerostomia | 2007 |
Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer.
Topics: Double-Blind Method; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Muscarinic Antagonists; Quinuclidines; Salivation; Thiophenes; Xerostomia | 2007 |
Randomized, double-blind, placebo- and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder.
Topics: Adult; Aged; Benzilates; Constipation; Double-Blind Method; Female; Humans; Japan; Male; Middle Aged; Muscarinic Antagonists; Quality of Life; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics; Xerostomia | 2007 |
The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjögren's syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study.
Topics: Adult; Aged; Aged, 80 and over; China; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Health Surveys; Humans; Middle Aged; Muscarinic Agonists; Oral Health; Patient Satisfaction; Quality of Life; Quinuclidines; Severity of Illness Index; Sjogren's Syndrome; Thiophenes; Xerostomia | 2008 |
A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Keratoconjunctivitis Sicca; Male; Middle Aged; Muscarinic Agonists; Placebos; Quinuclidines; Safety; Saliva; Sjogren's Syndrome; Tears; Thiophenes; Xerostomia | 2002 |
Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Agonists; Quinuclidines; Sjogren's Syndrome; Thiophenes; Xerostomia | 2002 |
General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 4th communication: Effects on gastrointestinal, urinary and reproductive systems and other effects.
Topics: Animals; Anti-Inflammatory Agents; Cardiovascular System; Cross-Over Studies; Digestive System; Dogs; Female; Guinea Pigs; Male; Mice; Mice, Inbred ICR; Muscarinic Agonists; Pregnancy; Quinuclidines; Rabbits; Rats; Rats, Wistar; Reproduction; Sjogren's Syndrome; Thiophenes; Urogenital System; Xerostomia | 2002 |
A comparative determination of side effects associated with the oral use of three anticholinergic-psychotropic drugs.
Topics: Adult; Chlordiazepoxide; Clinical Trials as Topic; Constipation; Fatigue; Female; Gastrointestinal Diseases; Headache; Heart Rate; Humans; Male; Middle Aged; Muscular Diseases; Parasympatholytics; Phenobarbital; Placebos; Propantheline; Quinuclidines; Scopolamine; Sex Factors; Tranquilizing Agents; Urination Disorders; Vision Disorders; Xerostomia | 1970 |
24 other study(ies) available for quinuclidines and Asialia
| Article | Year |
|---|---|
Comparing the effectiveness and adverse effects of pilocarpine and cevimeline in patients with hyposalivation.
Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Middle Aged; Muscarinic Agonists; Pilocarpine; Quinuclidines; Retrospective Studies; Thiophenes; Time Factors; Xerostomia | 2019 |
Long-term Use of the Sialogogue Medications Pilocarpine and Cevimeline Can Reduce Xerostomia Symptoms and Increase Salivary Flow in Head and Neck Cancer Survivors After Radiotherapy.
Topics: Head and Neck Neoplasms; Humans; Pilocarpine; Quinuclidines; Survivors; Thiophenes; Xerostomia | 2017 |
A prospective, observational study to assess the association between dry mouth and solifenacin treatment in patients with overactive bladder syndrome.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Male; Medication Adherence; Middle Aged; Muscarinic Antagonists; Prospective Studies; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Xerostomia; Young Adult | 2015 |
Salivary gland ultrasonography as a primary imaging tool for predicting efficacy of xerostomia treatment in patients with Sjögren's syndrome.
Topics: Administration, Oral; Aged; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Middle Aged; Muscarinic Agonists; Parasympathomimetics; Pilocarpine; Prednisolone; Prognosis; Quinuclidines; Retrospective Studies; Salivary Glands; Severity of Illness Index; Sjogren's Syndrome; Therapeutic Irrigation; Thiophenes; Treatment Outcome; Ultrasonography; Xerostomia | 2016 |
Sjögren's syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline treatment.
Topics: Bodily Secretions; Diagnosis, Differential; Drug Resistance; Humans; Hypergammaglobulinemia; Middle Aged; Muscarinic Agonists; Quinuclidines; Saliva; Sjogren's Syndrome; Thiophenes; Xerostomia | 2009 |
Abnormal subcellular localization of AQP5 and downregulated AQP5 protein in parotid glands of streptozotocin-induced diabetic rats.
Topics: Animals; Aquaporin 5; Blotting, Western; Cell Membrane; Cyclic GMP; Cytoplasm; Diabetes Mellitus, Experimental; Down-Regulation; Hypoglycemic Agents; Immunohistochemistry; Insulin; Male; Membrane Proteins; Muscarinic Agonists; Nitric Oxide; Parotid Gland; Protein Transport; Quinuclidines; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Thiophenes; Time Factors; Xerostomia | 2011 |
Effects of pilocarpine hydrochloride and cevimeline on submandibular/sublingual salivation in rat xerostomia model produced by X-ray irradiation.
Topics: Animals; Antipsychotic Agents; Body Temperature; Cardiovascular System; Central Nervous System; Chlorpromazine; Dose-Response Relationship, Drug; Male; Muscarinic Agonists; Pilocarpine; Quinuclidines; Radiation Injuries, Experimental; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Receptors, Muscarinic; Respiratory System; Salivary Proteins and Peptides; Salivation; Submandibular Gland; Thiophenes; Xerostomia | 2003 |
Cevimeline gargle for the treatment of xerostomia in patients with Sjögren's syndrome.
Topics: Administration, Oral; Adult; Aged; Female; Humans; Male; Middle Aged; Mouthwashes; Parasympathomimetics; Quinuclidines; Sjogren's Syndrome; Thiophenes; Xerostomia | 2004 |
[Clinical significance of cevimeline hydrochloride in the treatment of dry mouth in patients with Sjögren's syndrome].
Topics: Female; Humans; Middle Aged; Muscarinic Agonists; Quinuclidines; Sjogren's Syndrome; Thiophenes; Xerostomia | 2004 |
Dentistry. Implications and management of xerostomia in the HIV patient.
Topics: Antiretroviral Therapy, Highly Active; Cholinergic Agents; HIV Infections; HIV Protease Inhibitors; Humans; Pilocarpine; Quinuclidines; Reverse Transcriptase Inhibitors; Thiophenes; Xerostomia | 2005 |
Solifenacin and darifenacin for overactive bladder.
Topics: Benzofurans; Drug Interactions; Humans; Intestinal Obstruction; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Incontinence; Xerostomia | 2005 |
Dentistry. Clinic assesses effect of medication on dry mouth syndrome.
Topics: Dental Health Services; Female; HIV Infections; Humans; Male; Quinuclidines; Thiophenes; Xerostomia | 2005 |
New approaches to preventing xerostomia.
Topics: Amifostine; Cytoprotection; Humans; Muscarinic Agonists; Neoplasms; Pilocarpine; Quinuclidines; Radiation Injuries; Radiation-Protective Agents; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Salivary Glands; Thiophenes; Xerostomia | 2006 |
Cevimeline reduced mouth dryness and increased salivary flow in patients with xerostomia complicating chronic graft-versus-host disease.
Topics: Adult; Graft vs Host Disease; Humans; Male; Middle Aged; Parasympathomimetics; Quinuclidines; Thiophenes; Xerostomia | 2006 |
[Revision of the recommendations of the Commission on Pharmacotherapy of the German Society for Rheumatology. Recommendations for supportive therapy for Sjögren's syndrome].
Topics: Bromhexine; Cyclosporine; Dry Eye Syndromes; Electric Stimulation Therapy; Expectorants; Humans; Muscarinic Antagonists; Ophthalmic Solutions; Pilocarpine; Quinuclidines; Sjogren's Syndrome; Thiophenes; Xerostomia | 2007 |
Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia.
Topics: Adult; Aged; Aged, 80 and over; Diarrhea; Dyspepsia; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Muscarinic Agonists; Nausea; Quinuclidines; Radiotherapy Dosage; Sweat; Thiophenes; Xerostomia | 2007 |
Effect of cevimeline on radiation-induced salivary gland dysfunction and AQP5 in submandibular gland in mice.
Topics: Animals; Aquaporin 5; Disease Models, Animal; Female; Fluorescent Antibody Technique; Mice; Mice, Inbred ICR; Muscarinic Agonists; Quinuclidines; Radiation Dosage; Reverse Transcriptase Polymerase Chain Reaction; Saliva; Secretory Rate; Submandibular Gland; Submandibular Gland Diseases; Thiophenes; Time Factors; X-Rays; Xerostomia | 2007 |
Cevimeline (Evoxac) for dry mouth.
Topics: Acetylcholine; Clinical Trials as Topic; Contraindications; Humans; Intestinal Absorption; Muscarinic Agonists; Nausea; Pilocarpine; Quinuclidines; Thiophenes; Xerostomia | 2000 |
A new medication for treatment of dry mouth in Sjögren's syndrome.
Topics: Contraindications; Humans; Muscarinic Agonists; Pilocarpine; Quinuclidines; Receptors, Muscarinic; Salivary Glands; Salivation; Sjogren's Syndrome; Thiophenes; Xerostomia | 2001 |
Salivary enhancement: current status and future therapies.
Topics: Animals; Aquaporin 1; Aquaporins; Blood Group Antigens; Cholinergic Agents; Cranial Irradiation; Dental Caries; Genetic Therapy; Humans; Parasympathomimetics; Pilocarpine; Quinuclidines; Salivary Glands; Sjogren's Syndrome; Thiophenes; Xerostomia | 2001 |
General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 1st communication: effects on general behavior and central nervous system.
Topics: Anesthetics, Intravenous; Animals; Anticonvulsants; Behavior, Animal; Body Temperature; Cats; Central Nervous System; Electroencephalography; Electroshock; Female; Male; Mice; Mice, Inbred ICR; Motor Activity; Muscarinic Agonists; Pain Measurement; Psychomotor Performance; Quinuclidines; Rats; Rats, Wistar; Reflex; Sjogren's Syndrome; Thiopental; Thiophenes; Xerostomia | 2002 |
General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 2nd communication: effects on somatic nervous system and on autonomic nervous system and smooth muscle.
Topics: Anesthetics; Animals; Autonomic Nervous System; Catecholamines; Cats; Guinea Pigs; Histamine Antagonists; Male; Mice; Mice, Inbred ICR; Muscarinic Agonists; Muscle Contraction; Muscle Relaxants, Central; Muscle, Smooth; Muscle, Smooth, Vascular; Neuromuscular Junction; Nictitating Membrane; Peripheral Nervous System; Pupil; Quinuclidines; Rabbits; Rats; Rats, Inbred F344; Rats, Wistar; Sjogren's Syndrome; Thiophenes; Xerostomia | 2002 |
General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 3rd communication: effects on respiratory and cardiovascular systems.
Topics: Animals; Atropine; Dogs; Electrocardiography; Guinea Pigs; Heart Atria; Hemodynamics; In Vitro Techniques; Male; Muscarinic Agonists; Muscarinic Antagonists; Myocardial Contraction; Quinuclidines; Regional Blood Flow; Respiratory Mechanics; Sjogren's Syndrome; Thiophenes; Xerostomia | 2002 |
Assessing salivary gland hypofunction--Part two.
Topics: Anti-Infective Agents, Local; Candidiasis, Oral; Dental Caries; Humans; Maltose; Mastication; Muscarinic Agonists; Pilocarpine; Quinuclidines; Saliva; Thiophenes; Xerostomia | 2002 |